CME Group Inc.
NASDAQWhy this matters: Three separate signals on CME Group are moving in the same direction this week. Options traders are buying more puts. Short sellers are rebuilding positions. And a Deutsche Bank downgrade from late August still hangs over the stock. The convergence is worth watching with October earnings six weeks out. The standout…
CME short interest surges 21.1% over the past week to 1.73% of free float, marking the sharpest climb since late August as bears rebuild positions ahead of October earnings.
Why this matters: Three separate signals on CME Group are moving in the same direction this week. Options traders are buying more puts. Short sellers are rebuilding positions. And a Deutsche Bank downgrade from late…
CME Group heads into September with a notable divergence: the stock is up 3.3% on the week while most of its closest peers are in the red, and the short retreat documented last week has continued without pause. Short…
Snapshot as of 20 Sept 2026
CME Group has continued to grind higher since the Deutsche Bank downgrade last week, and the most notable development this week is not what bears are doing — it's what they're stopping doing. Short sellers have been…
CME Group enters the back half of August with a rare tension: the stock is having its best month in years, yet its largest bellwether analyst downgrade just landed this morning. The price action is striking on its own…
CME Group reported earnings this morning and the most striking disconnect is between options traders who have abruptly swung to their most call-heavy posture in months and short sellers who quietly rebuilt positions…
CME Group heads into its July 22 earnings print with analysts cutting targets in unison, shorts rebuilding at a notable pace, and the stock down 10% over the past month — a rare combination of valuation reset and…
CME Group heads into its July 22 earnings with an interesting split: a fresh analyst upgrade sitting against a stock that has shed 12% in a month, with options positioning quietly turning more constructive. The analyst…
CME Group reports its Q2 results on June 9 against a backdrop of genuine tension: the stock has shed 10% over the past month to $257.40, yet options traders are the most bullish on the name they've been all year. The…
CME Group heads into its May 14 Q1 results with the stock under pressure, analyst targets moving in conflicting directions, and valuation multiples in a quiet decline. The most telling signal this week is in analyst…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CME — free to start on ORTEX.
Sign up for free →Open CME on ORTEX